![Richard Steinhart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Steinhart
Direttore Finanziario/CFO presso BIOXCEL THERAPEUTICS, INC.
Patrimonio netto: 12 487 $ in data 31/05/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Steven Quay | M | 73 | 16 anni | |
Steve O'Loughlin | M | 39 | 9 anni | |
Vimal Mehta | M | 63 | 7 anni | |
Sean Power | M | 42 | 13 anni | |
Peter Mueller | M | 68 | 7 anni | |
Shu-Chih Chen | M | 62 | 16 anni | |
Sandesh Seth | M | 60 | 12 anni | |
Heather Rees | F | 51 | 7 anni | |
Delly Behen | F | - | 10 anni | |
June Bray | F | 70 | 3 anni | |
Avinash Desai | M | - | 4 anni | |
Eric van Zanten | M | - | 2 anni | |
Jeffrey Chell | M | 70 | 6 anni | |
Michal Votruba | M | 58 | 5 anni | |
Michael Miller | M | 67 | 2 anni | |
Rajiv Patni | M | 55 | 1 anni | |
Javier Rodriguez | M | 52 | 3 anni | |
Stephen Galli | M | 77 | 13 anni | |
Thomas Walker MacAllister | M | - |
Remedy Pharmaceuticals, Inc.
![]() Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | 8 anni |
Ajit Shetty | M | 77 | 7 anni | |
H. Remmel | M | 72 | 12 anni | |
Sandeep Laumas | M | 56 | 7 anni | |
Jenna A. Bosco | F | - | 13 anni | |
C. Nicholson | M | 69 | 16 anni | |
Erik Kopp | M | - | 3 anni | |
Monideepa Roy | M | - | 3 anni | |
Stephen Dressel | M | - | - | |
Sunitha Lakshminarayanan | F | - | - | |
Jenny Hsieh | F | - | - | |
Richard Graydon | M | - | 2 anni | |
Brennan Doyle | M | - | - | |
Lynn M. Bodarky | F | 58 | 1 anni | |
Roger Ulrich | M | - |
Remedy Pharmaceuticals, Inc.
![]() Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | 8 anni |
Paul Diamond | M | - | 3 anni | |
Mary Mei Chen | M | - | 4 anni | |
Gary Siegel | M | 66 | 7 anni | |
Chetan Lathia | M | - | - | |
Matthew Wiley | M | 52 | 2 anni | |
Frank Yocca | M | 68 | 7 anni | |
Jonathan Finn | M | 50 | 1 anni | |
Vincent O'Neill | M | 55 | 7 anni | |
Arezoo Mirad | M | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Richard Steinhart
- Contatti personali